TG THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 482575000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2026-06-30) |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:14.432113+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5ef675aa-baef-449e-8673-d2f6a22f047d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-26-025955Retrieved: 2026-08-19T09:42:14.432113+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/cash-and-equivalents/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5ef675aa-baef-449e-8673-d2f6a22f047d
History
- no predecessors — first report